PERFUSE THERAPEUTICS
Perfuse Therapeutics specializes in developing therapies for the treatment of eye disease. The company is pursuing a novel mechanism to treat various eye diseases, starting with glaucoma, by improving retinal perfusion.
PERFUSE THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.perfusetherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail Unified Layer Google DNS Google Domains
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
AntiRadical Therapeutics
AntiRadical Therapeutics focuses on developing drugs for the treatment of blood flow disruption.
Electra Therapeutics
Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.
Current Employees Featured
Founder
Investors List
OrbiMed
OrbiMed investment in Venture Round - Perfuse Therapeutics
Official Site Inspections
http://www.perfusetherapeutics.com
- Host name: box5917.bluehost.com
- IP address: 162.241.30.56
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Perfuse Therapeutics"
About Us - Perfuse Therapeutics
Michelle joined Perfuse in 2021 as the head of clinical development and translational sciences at Perfuse. She is a skilled clinical and translational leader with significant experience in ocular …See details»
Perfuse Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Perfuse Therapeutics specializes in developing therapies for the treatment of eye disease. The company is pursuing a novel mechanism to …See details»
Team - Perfuse Therapeutics
Michelle joined Perfuse in 2021 as the head of clinical development and translational sciences at Perfuse. She is a skilled clinical and translational leader with significant experience in ocular …See details»
Perfuse Therapeutics - LinkedIn
Perfuse Therapeutics is a clinical-stage biopharmaceutical company committed to reducing the incidence of blindness. Our mission is to develop novel therapeutics to protect and improve …See details»
Perfuse Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Perfuse Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Perfuse Therapeutics - Overview, News & Similar companies
Apr 4, 2023 View Perfuse Therapeutics (www.perfusetherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
Perfuse Therapeutics - PitchBook
Perfuse Therapeutics General Information Description. Operator of a biotechnology company intended to provide a novel mechanism to improve retinal perfusion in the context of various retinal diseases.See details»
Perfuse Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Perfuse Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, Disease Domain:Endocrinology and ...See details»
Perfuse Therapeutics - Company Profile - Tracxn
Dec 13, 2024 Website: perfusetherapeutics.com; Email ID: *****@perfusetherapeutics.com; Key Metrics. Latest Funding Round. Series A, Jul 2020, Undisclosed. Investors. Access Industries …See details»
Perfuse Therapeutics Information - RocketReach
Perfuse Therapeutics is a clinical-stage biopharmaceutical company committed to reducing the incidence of blindness. Our mission is to develop novel therapeutics to protect and improve …See details»
Perfuse Therapeutics - Products, Competitors, Financials, …
Perfusetherapeutics.com. Overview & Products; Financials; People; Founded Year 2018. Stage Series A | Alive. Total Raised $11M. Last Raised $9M | 4 yrs ago. About Perfuse …See details»
Perfuse Therapeutics Company Profile: Overview and Full News …
Perfusetherapeutics.com. Overview: Perfuse Therapeutics. Perfuse Therapeutics, based in California, is a company dedicated to developing innovative therapies aimed at reducing …See details»
Perfuse Therapeutics Financial Overview, Employee Count, and ...
Perfuse Therapeutics is a clinical-stage biopharmaceutical company committed to reducing the incidence of blindness. Our mission is to develop novel therapeutics to protect and improve …See details»
Company Information - RocketReach
Perfuse Therapeutics employs 13 employees. The Perfuse Therapeutics management team includes Michelle Chen (Vice President, Head of Clinical Development), Phillip Lai (Chief …See details»
Perfuse Therapeutics - VentureRadar
Similar Companies: Nona Biosciences USA n/a Nona Biosciences is a leading global biotechnology company dedicated to cutting edge technology innovations. We provide a total …See details»
Perfuse Therapeutics | Catalio Capital Management
Perfuse Therapeutics is a seed-stage biotechnology company focusing on improving retinal perfusion with a novel mechanism. Perfuse is developing therapies for several retinal diseases …See details»
Perfuse Therapeutics - Raised Funding from 5 investors - Tracxn
Dec 6, 2024 SageTech Medical Equipment - Paignton based, raised a funding of $823K in Seed round held on 20 Nov, 2024.; Billion Hearts Software Technologies - Bengaluru based, raised a funding of $4M in Seed round held on 20 Nov, 2024.; Cyera - Tel Aviv based, raised a funding of $300M in Series D round held on 20 Nov, 2024.; Rebike - Munich based, raised a funding of …See details»
Perfuse Therapeutics Announces FDA Clearance of IND …
Apr 4, 2023 This milestone marks transition of Perfuse Therapeutics to a clinical-stage company. SAN FRANCISCO, CA (April 4, 2023)– Perfuse Therapeutics, a biopharmaceutical company …See details»
Perfuze Company Profile 2024: Valuation, Funding & Investors
Perfuze General Information Description. Operator of a medical device company designed to treat acute ischemic stroke in patients. The company provides clinical outcomes in short procedural …See details»